Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
[The Effects of Sibutramine and Orlistat on the Ultrasonographic Findings, Insulin Resistance and Liver Enzyme Levels in Obese Patients with Non-Alcoholic Steatohepatitis]
Romanian Journal of Gastroenterology, 12(3):189-192
Lectura recomendada:
First Episode Psychosis: Early Intervention Strategies with Second-Generation Antipsychotic Medications
International Journal of Clinical Practice, 57(6):513-518
Lectura recomendada:
[Diarrhea Caused by Enterotoxigenic Escherichia coli Infection of Humans is Inhibited by Dietary Calcium]
Gastroenterology, 125(2):469-476
Lectura recomendada:
[Physical Activity Reduces Genetic Susceptibility to Increased Central Systolic Pressure Augmentation: A Study of Female Twins]
Journal of the American College of Cardiology, 42(2):264-270
Lectura recomendada:
[Oral Retinoid Therapy for Dermatologic Conditions inChildren and Adolescents]
Journal of the American Academy of Dermatology, 49:171-182
Lectura recomendada:
[Plasma Homocysteine and S-Adenosylmethionine in Erythrocytes as Determinants of Carotid Intima-Media Thickness: Different Effects in Diabetic and Non-Diabetic Individuals. The Hoorn Study]
Atherosclerosis, 169:323-330
Lectura recomendada:
[Clinical Significance of High-Density Lipoproteins and the Development of Atherosclerosis: Focus on the Role of the Adenosine Triphosphate-Binding Cassette Protein A1 Transporter]
American Journal of Cardiology, 92(Suppl):10-16
Lectura recomendada:
[Current and Future Aims of Lipid-Lowering Therapy: Changing Paradigms and Lessons from the Heart Protection Study on Standards of Efficacy and Safety]
American Journal of Cardiology, 92(Suppl.):3-9
Lectura recomendada:
Diuretic versus α-Blocker as First-Step Antihypertensive Therapy. Final Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Hypertension, 42:239-246
Lectura recomendada:
PI-5 the COX-2 Specific Inhibitor, MK-0966, is Effective in the Treatment of Primary Dysmenorrhea
Clinical Pharmacology & Therapeutics, 65(2):118
